Top Stories

Pitt sees 10% increase in COVID-19 vaccine card submissions

Pitt officials said Thursday that more than three-quarters of all Pittsburgh campus undergraduate students have uploaded proof of vaccination against COVID-19, according to an email sent by the COVID-19 Medical Response Office.

According to the email, there has been a 10% increase in the number of Pitt affiliates who have uploaded proof of vaccination. While 74% of undergraduate students across all campuses are vaccinated, 48% of graduate students are, along with 66% of faculty and 69% of staff.

On the Pittsburgh campus, 77% of undergraduate students have reported their vaccination status. 95% of undergraduates living on campus and 56% of those living off campus submitted proof of vaccination. 69% of faculty and 71% of staff on the Pittsburgh campus have reported their vaccination status.

Pitt’s mandatory weekly testing begins Monday, with all members of the University community who are unvaccinated or have yet to disclose their vaccination status being required to comply with regular COVID-19 testing, as part of the University’s health guidelines.

The COVID-19 Delta variant, which is the predominant strain of the virus currently in the United States, is nearly twice as contagious as previous variants, according to the Centers for Disease Control and Prevention. But according to the Kaiser Family Foundation, a nonprofit which compiles health policy information, so-called “breakthrough” infections among people who are fully vaccinated against COVID-19 are extremely rare. Based on state data analyzed by KFF, the breakthrough case rate is well below 1%, hospitalization rate ranged from effectively zero to 1% and the death rate was effectively zero.

In light of the federal government approving the Pfizer COVID-19 vaccine Monday, Pitt said in the email that this “should continue to give people confidence in vaccinations as a safe and effective tool.”

Melissa McGivney, deputy director of the CMRO, associate dean for community partnerships and professor of pharmacy and therapeutics in Pitt’s School of Pharmacy, commented in the email on the approval.

“Pfizer’s full approval is an important step in the fight against this public health crisis,” the email said. “All COVID-19 vaccines have been and remain safe and effective. We hope that with the formal approval of the Pfizer vaccine, more people will get vaccinated.”

newsdesk

Share
Published by
newsdesk

Recent Posts

What Trump’s win means for the future of reproductive rights 

Pitt professors give their opinions on what future reproductive health care will look like for…

35 minutes ago

Police blotter: Nov. 8 – Nov. 20

Pitt police reported one warrant arrest for indecent exposure at Forbes and Bouquet, the theft…

37 minutes ago

Down to their last strike, Pitt men’s soccer’s No. 2 seeding provides new hope in the NCAA tournament

Now down to their last strike, the time has come for 2024 Pitt men’s soccer…

40 minutes ago

Pitt’s winter sports well underway and preparing for holiday break contests

Wrestling Pitt wrestling (1-0, ACC 0-0) is in full swing and hosts Lehigh this Sunday,…

43 minutes ago

NFL playoff predictions and the NBA’s breakout rookie star in this week’s Take Four

The Eagles could go all the way // Ashley O’Doherty, Staff Writer  After their dominant…

46 minutes ago

Pitt volleyball prepares for Thanksgiving week matchups

Coming off four straight sweeps at the Fitzgerald Field House against UNC, Duke, Florida State…

49 minutes ago